Of 121 BRCA1 PSV carriers who underwent biopsy, 18 were diagnosed with DCIS (15.2%), and 8/81 BRCA2 PSV carriers were also diagnosed with DCIS (10.1%) (p > 0.05) (Figure 1). This evidence concerns the gene BRCA2 and ductal breast carcinoma in situ.